Sanofi SA (SNY)
46.61
-1.08
(-2.26%)
USD |
NASDAQ |
Apr 24, 16:00
46.68
+0.07
(+0.15%)
After-Hours: 20:00
Sanofi Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -1.554B |
| June 30, 2021 | -8.795B |
| June 30, 2020 | 8.893B |
| June 30, 2019 | -185.36M |
| June 30, 2018 | -15.62B |
| June 30, 2017 | 3.617B |
| June 30, 2016 | -1.661B |
| June 30, 2015 | -1.135B |
| June 30, 2014 | -2.952B |
| June 30, 2013 | -855.52M |
| June 30, 2012 | -1.144B |
| Date | Value |
|---|---|
| June 30, 2011 | -19.98B |
| June 30, 2010 | -2.721B |
| June 30, 2009 | -3.596B |
| June 30, 2008 | -1.081B |
| June 30, 2007 | -786.91M |
| June 30, 2006 | 94.49M |
| June 30, 2005 | -506.22M |
| June 30, 2004 | -224.14M |
| June 30, 2003 | -205.63M |
| June 30, 2002 | -927.62M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.795B
Minimum
Jun 2021
8.893B
Maximum
Jun 2020
-410.42M
Average
-869.72M
Median
Cash from Investing (Quarterly) Benchmarks
| AstraZeneca PLC | -1.077B |
| GSK PLC | 374.35M |
| Novo Nordisk A/S | -2.112B |
| Regeneron Pharmaceuticals Inc | -66.20M |
| Inhibrx Inc | -3.442M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | 16.67% |